CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Stockholders' Equity (Deficit)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Treasury stock, at cost
Balance at Dec. 31, 2024		$ 50,121	$ 14	$ 912,241	$ (862,106)	$ 665	$ (693)
Balance (in Shares) at Dec. 31, 2024			131,136,712
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of RSUs (in shares)			828,282
Exercise of common stock options		232		232
Exercise of common stock options (in shares)			77,515
Exercise of common warrants		517		517
Exercise of common warrants (in shares)			239,201
Reclassification of warrant liability to common stock warrants		1,241		1,241
Stock-based compensation expense		6,283		6,283
Issuance of common warrants		5,766		5,766
Net loss	$ (58,579)	(58,579)			(58,579)
Foreign currency translation adjustment	993	992				992
Balance at Mar. 31, 2025		6,573	$ 14	926,280	(920,685)	1,657	(693)
Balance (in Shares) at Mar. 31, 2025			132,281,710
Balance at Dec. 31, 2025		(86,235)	$ 15	961,991	(1,051,359)	3,811	(693)
Balance (in Shares) at Dec. 31, 2025			135,372,269
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of RSAs (in shares)			4,545
Exercise of common stock options		250		250
Exercise of common stock options (in shares)			26,194
Exercise of common warrants		13		13
Exercise of common warrants (in shares)			1,500
Stock-based compensation expense		7,403		7,403
Net loss	(10,621)	(10,621)			(10,621)
Foreign currency translation adjustment	$ (777)	(777)				(777)
Balance at Mar. 31, 2026		$ (89,967)	$ 15	$ 969,657	$ (1,061,980)	$ 3,034	$ (693)
Balance (in Shares) at Mar. 31, 2026			136,059,569